VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, December 31, 2025
Stock Comparison
Nasdaq, Inc. vs Sanofi
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Nasdaq, Inc.
NDAQ · NASDAQ
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Nasdaq, Inc.'s moat claims, evidence, and risks.
View NDAQ analysisSanofi
SAN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Nasdaq, Inc. leads (76 / 100 vs 74 / 100 for Sanofi).
- Segment focus: Nasdaq, Inc. has 3 segments (42.4% in Capital Access Platforms); Sanofi has 3 segments (79.8% in Pharma (Prescription Medicines)).
- Moat breadth: Nasdaq, Inc. has 9 moat types across 5 domains; Sanofi has 5 across 3.
Primary market context
Nasdaq, Inc.
Capital Access Platforms
Issuer and investor solutions: listings, index licensing, market data, and investment analytics/workflow platforms
Global (with major exposure to U.S. and Nordic/Baltic markets)
Public/private companies (issuers), asset managers, institutional investors, data subscribers
Listing venue + index administrator/licensor + data/analytics provider
42.4%
Sanofi
Pharma (Prescription Medicines)
Branded prescription pharmaceuticals (immunology, rare disease, neurology, oncology, general medicines)
Global
Patients via payers/providers and channel partners (wholesalers, pharmacies, hospitals)
Research-based drug developer, manufacturer, and marketer
79.8%
Side-by-side metrics
Moat coverage
Shared moat types
Nasdaq, Inc. strengths
Sanofi strengths
Segment mix
Nasdaq, Inc. segments
Full profile >Market Services
Competitive
Capital Access Platforms
Oligopoly
Financial Technology
Competitive
Sanofi segments
Full profile >Pharma (Prescription Medicines)
Oligopoly
Vaccines
Oligopoly
Opella (Consumer Healthcare - Sanofi minority stake)
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.